NCT05679375View on ClinicalTrials.gov

IV and Intrathecal Ketamine in Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Cesarean SectionAnalgesia
Interventions
DRUG

Intrathecal ketamine

Patients will receive intrathecal Ketamine 0.1mg/kg added to bupivacaine and morphine

DRUG

Intravenous ketamine

Patients will receive IV Ketamine 0.25mg/kg after spinal

Trial Locations (1)

Unknown

Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER